Agenda

DAY 1
DAY 2
Session II
HER2+, Continued
Friday, September 18, 2026
4:25 pm
5:50 pm
Session Moderator(s)
PRESENTATIONS IN THIS SESSION

Session Introduction

Reshma L. Mahtani, DO

Transforming Outcomes in Metastatic HER2-Postive Breast Cancer

Abi Siva, MD

CNS Metastases in HER2-Positive Breast Cancer: Closing the Therapeutic Gap

Manmeet Ahluwalia, MD, MBA, FASCO

The Balancing Act: Endocrine Meets HER2 in Triple-Positive Disease

Nan Chen, MD

Audience Q&A and Panel Discussion

Reshma L. Mahtani, DO; Manmeet Ahluwalia, MD, MBA, FASCO; Nan Chen, MD; Abi Siva, MD